These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
393 related items for PubMed ID: 9102396
21. How common is rhabdomyolysis in patients receiving lipid-lowering therapy? Phillips PS. Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):130-1. PubMed ID: 16265453 [No Abstract] [Full Text] [Related]
24. Efficacy and safety of atorvastatin in the treatment of hypercholesterolemia associated with antiretroviral therapy. Palacios R, Santos J, González M, Ruiz J, Valdivielso P, Márquez M, González-Santos P. J Acquir Immune Defic Syndr; 2002 Aug 15; 30(5):536-7. PubMed ID: 12154347 [No Abstract] [Full Text] [Related]
25. Acute pancreatitis possibly associated with combined salicylate and atorvastatin therapy. Miltiadous G, Anthopoulou A, Elisaf M. JOP; 2003 Jan 15; 4(1):20-1. PubMed ID: 12555012 [No Abstract] [Full Text] [Related]
26. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Higashi K, Kihara T, Sawada S, Iwamoto N, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F. J Am Coll Cardiol; 2005 Mar 01; 45(5):733-42. PubMed ID: 15734619 [Abstract] [Full Text] [Related]
27. Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance. Sinzinger H, Kritz H, Furberg CD. Med Sci Monit; 2003 Jul 01; 9(7):PI88-92. PubMed ID: 12883464 [Abstract] [Full Text] [Related]
30. The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy. Yamamoto A, Harada-Shiba M, Kawaguchi A, Oi K, Kubo H, Sakai S, Mikami Y, Imai T, Ito T, Kato H, Endo M, Sato I, Suzuki Y, Hori H. Atherosclerosis; 2000 Nov 01; 153(1):89-98. PubMed ID: 11058703 [Abstract] [Full Text] [Related]
31. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group. Diabetes Obes Metab; 2005 Jul 01; 7(4):430-8. PubMed ID: 15955130 [Abstract] [Full Text] [Related]
33. Efficacy and safety of chunghyul-dan (qingwie-dan) in patients with hypercholesterolemia. Cho KH, Kang HS, Jung WS, Park SU, Moon SK. Am J Chin Med; 2005 Jul 01; 33(2):241-8. PubMed ID: 15974483 [Abstract] [Full Text] [Related]
34. Simultaneous treatment of blood pressure and cholesterol beats the 'SILO' approach in lowering cardiovascular risk: results of the CRUCIAL study. Aalbers J. Cardiovasc J Afr; 2011 Jul 01; 22(2):101. PubMed ID: 21556456 [No Abstract] [Full Text] [Related]
37. Efficacy of vitamin E compared with either simvastatin or atorvastatin in preventing the progression of atherosclerosis in homozygous familial hypercholesterolemia. Raal FJ, Pilcher GJ, Veller MG, Kotze MJ, Joffe BI. Am J Cardiol; 1999 Dec 01; 84(11):1344-6, A7. PubMed ID: 10614803 [Abstract] [Full Text] [Related]
40. Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin. Trifiletti A, Lasco A, Scamardi R, Pizzoleo MA, Gaudio A, La Rocca R, Morini E, Frisina N. Pathophysiol Haemost Thromb; 2003 Dec 01; 33(2):84-7. PubMed ID: 14624049 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]